Question 1

What is DROXIDOPA used for?

Accepted Answer

DROXIDOPA (brand name droxidopa) is a Other indicated for 1 INDICATIONS AND USAGE Droxidopa capsules indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out” in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson's disease [PD].

Question 2

How does DROXIDOPA work?

Accepted Answer

DROXIDOPA works through the following mechanism: 12.1 Mechanism of Action The exact mechanism of action of droxidopa in the treatment of neurogenic orthostatic hypotension is unknown. Droxidopa is a synthetic amino acid analog that is directly metabolized to norepinephrine by dopa-decarboxylase, which is extensively distributed throughout the body. Droxidopa is believed to exert its pharmacological effects through norepinephrine and not through the parent molecule or other metabolites. Norepinephrine increases blood pressure by inducing peripheral arterial and venous vasoconstriction. Droxidopa in humans induces small and transient rises in plasma norepinephrine..

Question 3

What are the most common side effects of DROXIDOPA?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for DROXIDOPA. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is DROXIDOPA the same as droxidopa?

Accepted Answer

droxidopa is a brand name for DROXIDOPA. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

DROXIDOPA

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations